IL91361A - Disubstituted 1,9-annelated [1,4] benzodiazepinone compounds, processes for the preparation thereof and pharmaceutical compositions containing the same - Google Patents

Disubstituted 1,9-annelated [1,4] benzodiazepinone compounds, processes for the preparation thereof and pharmaceutical compositions containing the same

Info

Publication number
IL91361A
IL91361A IL9136189A IL9136189A IL91361A IL 91361 A IL91361 A IL 91361A IL 9136189 A IL9136189 A IL 9136189A IL 9136189 A IL9136189 A IL 9136189A IL 91361 A IL91361 A IL 91361A
Authority
IL
Israel
Prior art keywords
alkyl
compound
salt
amino
formula
Prior art date
Application number
IL9136189A
Other languages
English (en)
Other versions
IL91361A0 (en
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888821257A external-priority patent/GB8821257D0/en
Priority claimed from GB888829265A external-priority patent/GB8829265D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of IL91361A0 publication Critical patent/IL91361A0/xx
Publication of IL91361A publication Critical patent/IL91361A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL9136189A 1988-09-09 1989-08-20 Disubstituted 1,9-annelated [1,4] benzodiazepinone compounds, processes for the preparation thereof and pharmaceutical compositions containing the same IL91361A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888821257A GB8821257D0 (en) 1988-09-09 1988-09-09 Tricyclic compounds
GB888829265A GB8829265D0 (en) 1988-12-15 1988-12-15 Tricyclic compounds

Publications (2)

Publication Number Publication Date
IL91361A0 IL91361A0 (en) 1990-03-19
IL91361A true IL91361A (en) 1994-10-07

Family

ID=26294376

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9136189A IL91361A (en) 1988-09-09 1989-08-20 Disubstituted 1,9-annelated [1,4] benzodiazepinone compounds, processes for the preparation thereof and pharmaceutical compositions containing the same

Country Status (18)

Country Link
US (2) US4981847A (fr)
EP (1) EP0360079B1 (fr)
JP (3) JPH0665673B2 (fr)
KR (1) KR900004737A (fr)
CN (1) CN1022187C (fr)
AU (1) AU628370B2 (fr)
DE (1) DE68912858T2 (fr)
DK (1) DK444789A (fr)
ES (1) ES2061848T3 (fr)
FI (1) FI92401C (fr)
HK (1) HK101996A (fr)
HU (2) HUT54152A (fr)
IE (1) IE62916B1 (fr)
IL (1) IL91361A (fr)
NO (1) NO171913C (fr)
PH (1) PH27358A (fr)
PT (1) PT91664B (fr)
RU (1) RU2007406C1 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2630440B1 (fr) * 1988-04-25 1991-09-20 Jouveinal Sa Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique
US5248679A (en) * 1988-09-09 1993-09-28 Fujisawa Pharmaceutical Co., Ltd. Tricyclic compounds
IL91361A (en) * 1988-09-09 1994-10-07 Fujisawa Pharmaceutical Co Disubstituted 1,9-annelated [1,4] benzodiazepinone compounds, processes for the preparation thereof and pharmaceutical compositions containing the same
IL93401A (en) * 1989-03-08 1994-08-26 Kali Chemie Pharma Gmbh H1 - Indole - 2 - Carboxylic acid 1, 7 - Consolidated N -) 1, 4 - Benzodiazepine - 3 - Il (amides, their preparation and drugs containing them
FR2652352A1 (fr) * 1989-09-28 1991-03-29 Jouveinal Sa Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique.
GB9018601D0 (en) * 1990-08-24 1990-10-10 Fujisawa Pharmaceutical Co Tricyclic compounds
CA2056809A1 (fr) * 1990-12-07 1992-06-08 Mark G. Bock Analogues de la benzodiazepine
EP0572235A3 (en) * 1992-05-28 1994-06-01 Tanabe Seiyaku Co Beta-carboline derivatives with anticholecystoquinine activity
GB2271354A (en) * 1992-10-07 1994-04-13 Merck Sharp & Dohme Tricyclic derivatives of benzodiazepines
FR2701708B1 (fr) * 1993-02-19 1995-05-19 Sanofi Elf Dérivés de 2-amido-4-phénylthiazoles polysubstitués, procédé de préparation, composition pharmaceutique et utilisation de ces dérivés pour la préparation d'un médicament.
KR960700753A (ko) * 1993-03-03 1996-02-24 후지야마 아키라 광학 이성화 억제제(optical isomerization inhibitor)
DE69429584T2 (de) * 1993-11-26 2002-08-08 Tanabe Seiyaku Co., Ltd. 2-oxoindolin-derivate als cholecystokinin rezeptor antagonisten
JPH10504545A (ja) * 1994-07-29 1998-05-06 藤沢薬品工業株式会社 ベンゾジアゼピン誘導体
FR2723739B1 (fr) * 1994-08-19 1997-02-14 Sanofi Sa Derives de glycinamide, procedes pour leur preparation et medicaments les contenant.
AU3265895A (en) * 1994-08-30 1996-03-22 Fujisawa Pharmaceutical Co., Ltd. Liposome preparation
FR2725719B1 (fr) * 1994-10-14 1996-12-06 Jouveinal Inst Rech Diazepino-indoles inhibiteurs de phosphodiesterases iv
US5716958A (en) 1994-10-27 1998-02-10 Tobishi Pharmaceutical Co., Ltd. Amino acid derivative having anti-CCK activity
AUPO284396A0 (en) 1996-10-08 1996-10-31 Fujisawa Pharmaceutical Co., Ltd. Benzodiazepine derivatives
FR2776660B1 (fr) * 1998-03-27 2000-05-12 Parke Davis Diazepino-indoles de phosphodiesterases iv
CN104797584A (zh) 2012-09-21 2015-07-22 百时美施贵宝公司 作为notch抑制剂的三环杂环化合物
CN104797569A (zh) 2012-09-21 2015-07-22 百时美施贵宝公司 取代的1,5-苯并二氮杂*酮化合物
WO2014047370A1 (fr) 2012-09-21 2014-03-27 Bristol-Myers Squibb Company Composés fluoroalkyl benzodiazépinones
US9242940B2 (en) 2012-09-21 2016-01-26 Bristol-Myers Squibb Company N-substituted bis(fluoroalkyl)-1,4-benzodiazepinone compounds
WO2014047392A1 (fr) 2012-09-21 2014-03-27 Bristol-Myers Squibb Company Composés fluoroalkyl-1,4-benzodiazépinones
JP2015531792A (ja) 2012-09-21 2015-11-05 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ １，４−ベンゾジアゼピノン化合物のプロドラッグ
EP2897942B1 (fr) 2012-09-21 2016-08-31 Bristol-Myers Squibb Company Composés de fluoralkyl- et de fluorocycloalkyl-1,4-benzodiazépinone utilisables en tant qu'inhibiteurs du récepteur notch
CN105308030A (zh) 2012-09-21 2016-02-03 百时美施贵宝公司 烷基、氟烷基-1,4-苯并二氮杂*酮化合物
EP2981267A1 (fr) 2013-04-04 2016-02-10 Bristol-Myers Squibb Company Traitement combiné pour le traitement de maladies prolifératives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3651083A (en) * 1969-11-03 1972-03-21 Upjohn Co Tetra- and hexahydro-phenylpyrrolo benzodiazepines and intermediates
AU2733371A (en) * 1970-04-14 1972-10-12 A. H. Robins Company, Incorporated 5, 7-DISUBSTITUTED-l, 9-ALKYLENE-l, 4-BENZODIAZEPIN-2 ONES
US3794646A (en) * 1970-04-14 1974-02-26 Robins Co Inc A H 5,7-disubstituted-1,9-tetramethylene-1,4-benzodiazepin-2-ones
CA1332410C (fr) * 1984-06-26 1994-10-11 Roger M. Freidinger Analogues de benzodiazepines
US4735941A (en) * 1986-12-23 1988-04-05 Merck & Co., Inc. 1,4-benzodiazepines with 5- and 6-membered heterocyclic rings, useful as gastrointestinal and CNS agents
FR2630440B1 (fr) * 1988-04-25 1991-09-20 Jouveinal Sa Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique
IL91361A (en) * 1988-09-09 1994-10-07 Fujisawa Pharmaceutical Co Disubstituted 1,9-annelated [1,4] benzodiazepinone compounds, processes for the preparation thereof and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
FI92401C (fi) 1994-11-10
JP2848230B2 (ja) 1999-01-20
NO171913B (no) 1993-02-08
PT91664A (pt) 1990-03-30
CN1022187C (zh) 1993-09-22
FI92401B (fi) 1994-07-29
IE62916B1 (en) 1995-03-08
DE68912858D1 (de) 1994-03-17
JPH0741480A (ja) 1995-02-10
EP0360079B1 (fr) 1994-02-02
ES2061848T3 (es) 1994-12-16
PH27358A (en) 1993-06-21
HK101996A (en) 1996-06-21
CN1040981A (zh) 1990-04-04
JPH0665673B2 (ja) 1994-08-24
RU2007406C1 (ru) 1994-02-15
DE68912858T2 (de) 1994-06-01
DK444789A (da) 1990-03-10
FI894169L (fi) 1990-03-10
KR900004737A (ko) 1990-04-12
US5155101A (en) 1992-10-13
NO893616L (no) 1990-03-12
DK444789D0 (da) 1989-09-08
US4981847A (en) 1991-01-01
NO171913C (no) 1993-05-19
PT91664B (pt) 1995-05-31
IE892840L (en) 1990-03-09
FI894169A0 (fi) 1989-09-05
JPH02111774A (ja) 1990-04-24
HUT54152A (en) 1991-01-28
EP0360079A1 (fr) 1990-03-28
AU628370B2 (en) 1992-09-17
AU4025789A (en) 1990-03-15
JPH0748373A (ja) 1995-02-21
IL91361A0 (en) 1990-03-19
NO893616D0 (no) 1989-09-08
HU211264A9 (en) 1995-11-28

Similar Documents

Publication Publication Date Title
US4981847A (en) Tricyclic compounds
AU656576B2 (en) Quinoline derivatives
EP0620216A1 (fr) Dérives de benzamide et leur utilisation comme antagonistes de vasopressine
WO1996004254A2 (fr) Derives de benzodiazepine
US5322842A (en) Tricyclic benzodiazepine derivates, their preparation, and pharmaceutical compositions containing them
JPWO1994011375A1 (ja) 三環式化合物
US5583135A (en) Heterotricyclic derivatives, process for their preparation and pharmaceutical compositions containing them
US5461048A (en) Tricyclic compounds having cholecystokinin antagonist activity
IE904580A1 (en) Quinazoline derivatives and their preparation
EP0669334A1 (fr) Compose tricyclique
JP2000514838A (ja) 成長ホルモンの放出を促進するピペリジノ誘導体
WO1993005035A1 (fr) Derives de quinazoline et leur preparation
JPH072873A (ja) 三環式化合物
JPH06336482A (ja) 三環式化合物

Legal Events

Date Code Title Description
RH Patent void